Zura Bio Limited
ZURA
$1.21
-$0.05-3.97%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -6.12% | 13.18% | 32.61% | 44.69% | -96.02% |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -38.83% | -45.23% | -61.75% | -79.49% | 72.33% |
| Change in Net Operating Assets | 12.67% | -54.91% | -3.66% | 153.66% | 14.29% |
| Cash from Operations | -103.57% | -86.50% | -98.75% | -99.65% | -293.66% |
| Capital Expenditure | -1,571.43% | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 100.00% | 37.50% | 68.93% | 47.62% | -60.67% |
| Cash from Investing | 99.10% | 36.56% | 68.74% | 47.50% | -22.81% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 100.00% |
| Issuance of Common Stock | 15.00% | -43.50% | -43.50% | -48.25% | 12.81% |
| Repurchase of Common Stock | -1,345.45% | -1,345.45% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 256.81% | 293.08% | 434.72% | 231.09% | 384.48% |
| Cash from Financing | 52.07% | -9.44% | -13.36% | -23.11% | 33.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 76.11% | -21.93% | -16.43% | -30.31% | 16.42% |